My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
Allocation Agreement with exhibits - final
>
Meetings
>
2022
>
09. September
>
2022-09-06 10:00 AM - Commissioners' Agenda
>
Allocation Agreement with exhibits - final
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
9/1/2022 1:11:41 PM
Creation date
9/1/2022 1:10:08 PM
Metadata
Fields
Template:
Meeting
Date
9/6/2022
Meeting title
Commissioners' Agenda
Location
Commissioners' Auditorium
Address
205 West 5th Room 109 - Ellensburg
Meeting type
Regular
Meeting document type
Supporting documentation
Supplemental fields
Item
Request to Approve a Resolution Authorizing the Chair's Signature on a Opioid Litigation Allocation Agreement
Order
3
Placement
Consent Agenda
Row ID
93293
Type
Agreement
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
106
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
FINAL AGREEMENT 3.25.22 <br />8. Provide training on MAT for health care providers, first responders, students, or <br />other supporting professionals, such as peer recovery coaches or recovery <br />outreach specialists, including telementoring to assist community-based providers <br />in rural or underserved areas. <br />9. Support workforce development for addiction professionals who work with <br />persons with OUD and any co-occurring SUD/MH conditions. <br />10. Offer fellowships for addiction medicine specialists for direct patient care, <br />instructors, and clinical research for treatments. <br />11. Offer scholarships and supports for behavioral health practitioners or workers <br />involved in addressing OUD and any co-occurring SUD/MH or mental health <br />conditions, including, but not limited to, training, scholarships, fellowships, loan <br />repayment programs, or other incentives for providers to work in rural or <br />underserved areas. <br />12. Provide funding and training for clinicians to obtain a waiver under the federal <br />Drug Addiction Treatment Act of 2000 ("DATA 2000") to prescribe MAT for <br />OUD, and provide technical assistance and professional support to clinicians who <br />have obtained a DATA 2000 waiver. <br />13. Disseminate of web -based training curricula, such as the American Academy of <br />Addiction Psychiatry's Provider Clinical Support Service—Opioids web -based <br />training curriculum and motivational interviewing. <br />14. Develop and disseminate new curricula, such as the American Academy of <br />Addiction Psychiatry's Provider Clinical Support Service for Medication— <br />Assisted Treatment. <br />B. SUPPORT PEOPLE IN TREATMENT AND RECOVERY <br />Support people in recovery from OUD and any co-occurring SUD/MH conditions <br />through evidence -based or evidence -informed programs or strategies that may include, <br />but are not limited to, the programs or strategies that: <br />1. Provide comprehensive wrap-around services to individuals with OUD and any <br />co-occurring SUD/MH conditions, including housing, transportation, education, <br />job placement, job training, or childcare. <br />2. Provide the full continuum of care of treatment and recovery services for OUD <br />and any co-occurring SUD/MH conditions, including supportive housing, peer <br />support services and counseling, community navigators, case management, and <br />connections to community-based services. <br />3. Provide counseling, peer -support, recovery case management and residential <br />treatment with access to medications for those who need it to persons with OUD <br />and any co-occurring SUD/MH conditions. <br />E-5 <br />
The URL can be used to link to this page
Your browser does not support the video tag.